Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dopamine D2/3 Receptor Availability”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Early research (Phase 1)Ended earlyNCT03059563
What this trial is testing

Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users

Who this might be right for
Dopamine D2/3 Receptor AvailabilityCognitive FunctionMethamphetamine Abuse
University of California, Los Angeles 62
Post-approval studies (Phase 4)Looking for participantsNCT06763172
What this trial is testing

Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI

Who this might be right for
HealthyCaffeineAdenosine+1 more
Hsiao-Ying Wey 12
Not applicableActive Not RecruitingNCT03911726
What this trial is testing

Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Central Institute of Mental Health, Mannheim 140